Day: June 30, 2020

Vast Resources plc / Ticker: VAST / Index: AIM / Sector: Mining30 June 2020Vast Resources plc(“Vast” or the “Company”)Manaila Polymetallic Mine UpdateVast Resources plc, the AIM-listed mining company, is pleased to update the market on progress at its Manaila Polymetallic Mine  and the adjacent Manaila Carlibaba Extension Project in Romania “Manaila”.The Company can confirm it has now been granted the Manaila Carlibaba Exploitation License which will allow the Company to re-examine the exploitation of the mineral resources within the larger Manaila Carlibaba license area.The Manaila Carlibaba exploitation perimeter contains a JORC 2012 compliant Measured and Indicated Mineral Resource of 3.6Mt grading 0.93% copper, 0.29% lead, 0.63% zinc, 0.23g/t gold and 24.9g/t silver with Inferred Mineral Resources of 1.0Mt grading 1.10% copper, 0.40%...

PRESS RELEASEJune 30, 2020                                                           During June, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has increased due to the exercising of warrants of series TO 1. As of June 30, 2020, the registered number of shares and votes in Saniona amounts to 30,383,316.For more information, please contact Rami Levin, President & CEO, Saniona, Mobile: +1 (781) 987 3144, Email: rami.levin@saniona.comAnita Milland, Interim CFO & Head of IR, Mobile +45-20163432, Email: anita.milland@saniona.comThis information is such information as Saniona AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 8:00 p.m. CET on June 30, 2020.About...

Basel, Switzerland, June 30, 2020Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into a lease agreement for office space and laboratories at the new innovation park GRID, which is currently being built by SENN Resources AG in Allschwil, in the canton of Basel-Landschaft. Basilea plans to move to its new corporate headquarters at the GRID in mid-2022.David Veitch, Chief Executive Officer, said: “Following the recent sale of our current corporate headquarter property, we are excited to now take the next important step towards moving the Basilea team, currently working at different locations across Basel, into one place. We will benefit from the close proximity to innovative start-up companies, academic institutions and other biotech companies in the emerging life sciences and technology cluster. Additionally,...

Basel, 30. Juni 2020Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass sie einen Mietvertrag für Büro- und Laborräume im neuen Innovationspark GRID abgeschlossen hat, der zurzeit von der SENN Resources AG in Allschwil, Kanton Basel-Landschaft, gebaut wird. Basilea plant, Mitte 2022 an ihren neuen Firmensitz im GRID umzuziehen.David Veitch, Chief Executive Officer, sagte: „Nach dem kürzlich erfolgten Verkauf unseres derzeitigen Firmensitzes freuen wir uns, nun den nächsten wichtigen Schritt zu unternehmen, um das Basilea-Team, das aktuell an verschiedenen Standorten in Basel arbeitet, an einem Ort zusammenzuführen. Durch die Nähe zu innovativen Start-ups, akademischen Institutionen und anderen Biotech-Unternehmen, können wir von dem aufstrebenden Life Sciences- und Technologie-Cluster profitieren. Zudem erwarten wir von diesem...

RESEARCH TRIANGLE PARK, N.C., June 29, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology, announced the pricing of an underwritten public offering of 9,375,000 shares of its common stock at a public offering price of $8.00, for total gross proceeds of $75 million, before deducting underwriting discounts and commissions and expenses payable by Liquidia. All of the shares in the offering will be sold by Liquidia. In addition, Liquidia has granted the underwriters a 30-day option to purchase up to an additional 1,406,250 shares of common stock at the public offering price, less the underwriting discount and commissions. The offering is expected to close on July...

RESEARCH TRIANGLE PARK, N.C., June 29, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology, will host a webcast and conference call on June 30, 2020 at 8:00 a.m. Eastern Time to provide an update on recent announcements regarding the proposed acquisition of RareGen, LLC, and the ongoing offering of common stock.Conference call details:Date: June 30, 2020Call start time: 8:00 a.m. Eastern TimeDomestic dial-in number: 1-877-707-8711International dial-in number: 1-857-270-6219Passcode: 4836889A live and archived webcast of the call will be available on the Events & Presentations page of Liquidia’s website.About LiquidiaLiquidia is a late-stage clinical biopharmaceutical...